

Cinnabsin is a homeopathic medicine used in sinusitis.
It has anti-inflammatory and anti-edema effects, reduces the increased secretion in the sinuses. Relieves nasal breathing. It promotes immunity.
In the complex treatment of acute and chronic inflammation of the paranasal sinuses (sinusitis, frontal, etc.).
1 tab .:
- Cinnabaris D3 25 mg
- Hydrastis D3 25 mg
- Kalium bichromicum D3 25 mg
- Echinacea D1 25 mg
Excipients: lactose, magnesium stearate, wheat starch.
No customer reviews for the moment.
For oral use.
In case of acute illness, children from 3 to 6 years old are prescribed 1 tab. every 2 hours (no more than 6 times / day) until the onset of improvement, then - 1/2 tab. 3 times / day until complete recovery.
Children from 6 to 12 years old appoint 1 tab. every hour (no more than 7-8 times / day) until the onset of improvement, then - 1 tab. 2 times / day until complete recovery.
Adults and children over 12 are prescribed 1 tab. every hour (no more than 12 times / day) before the onset of improvement, then - 1-2 tab. 3 times / day until complete recovery.
In case of chronic diseases, children from 3 to 6 years old are prescribed in 1/2 tab. 3 times / day; children from 6 to 12 years old - 1 tab. 2 times / day; adults and children over 12 are prescribed 1 tab. 3 times / day to improve the condition.
The course of treatment for the prevention of recurrence in the chronic course of the disease - up to 2 months.
Zinnabsin pills should be taken 30 minutes before or 30 minutes after a meal, slowly dissolving in the mouth. Children from 3 to 5 years old are recommended to dissolve the tablet in a small amount of liquid or give it in a crushed form under the tongue.
Possible: allergic reactions; in rare cases - skin reactions, with the development of which the drug should be canceled.
After the use of the drug, salivation may be observed (in this case, reduce the dose or stop taking the drug).
- Hypersensitivity to the drug.
It is not recommended to prescribe the drug to children under the age of 3 years due to the lack of clinical data.
Drug interaction of the drug Zinnabsin with other drugs is not installed.
Use of the drug Cinnabsin during pregnancy and lactation (breastfeeding) is possible only if the intended benefits to the mother outweigh the potential risk to the fetus and child.
With the use of Zinnabsin may be a temporary deterioration. In this case, the patient should stop taking the drug and consult a doctor.
When using Zinnabsin, the use of other drugs is allowed.
The patient should be informed that in the absence of a therapeutic effect within 3 days the drug should be withdrawn and consult a doctor.
Taking Cinnabsin may have a negative effect on patients with celiac disease and lactose intolerance.
Currently, cases of drug overdose Zinnabsin were reported.